Sensitivity to Tyrosine Kinase Inhibitors in a Human Philadelphia Chromosome-Positive (Ph+) Leukemia Model With the T315I-Inclusive Compound Mutation

Thao T Nguyen,Minori Tamai,Daisuke Harama,Keiko Kagami,Chiaki Komatsu,Shin Kasai,Koshi Akahane,Kumiko Goi,Takeshi Inukai

doi:10.7759/cureus.76538

Sensitivity to Tyrosine Kinase Inhibitors in a Human Philadelphia Chromosome-Positive (Ph+) Leukemia Model With the T315I-Inclusive Compound Mutation

Thao T Nguyen, Minori Tamai + Show 7 more

https://doi.org/10.7759/cureus.76538

Copy DOI

Export

Save

Cite

Journal: Cureus

Publication Date: Dec 28, 2024

#Leukemia Model #Philadelphia Chromosome-Positive Leukemia #Chromosome-Positive Leukemia #Compound Mutation #Tyrosine Kinase Inhibitors #Tyrosine Kinase #Kinase Inhibitors

Abstract
Full-Text
Similar Papers

Abstract

Listen

Sensitivity to Tyrosine Kinase Inhibitors in a Human Philadelphia Chromosome-Positive (Ph+) Leukemia Model With the T315I-Inclusive Compound Mutation

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Cureus

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Sensitivity to Tyrosine Kinase Inhibitors in a Human Philadelphia Chromosome-Positive (Ph+) Leukemia Model With the T315I-Inclusive Compound Mutation